Abstract

Objective:

In this retrospective study, we assessed if the admission levels of interleukin (IL)-6 and other inflammatory parameters corralate with the extension of lung involvement on computed tomography (CT) in severe-critical COVID patients.

Materials and Methods:

Ninety patients with a diagnosis of COVID-19 in the intensive care unit were included; however, 30 of these patients who were diagnosed as COVID-19 [polymerase chain reaction (PCR), CT, or history-clinical presentation-laboratory] and whose CT and IL-6 inflamatory parameter results could be obtained were finally analyzed.

Admission CT scan findings were analyzed according to a 40-point system, and compared to the admission levels of plasma IL-6 as well as c-reactive protein, procalcitonin, lymphocyte, and neutrophyl/lymphocyte ratios.

Results:

No correlation was found between the IL-6 levels and CT scores taken in the same time period. IL-6 levels were corraleted with procalcitonin levels and mortality rate ssuggesting that bacterial infections were supervened on the clinical scene of these patients.

Conclusion:

In our study, we could not show any correlation between CT scores and an elevation of IL-6 levels. The role of the cytokine storm in COVID-19 pneumonia that manifests with cell death, thrombotic sequences, and alveolar edema might be explained by ongoing studies.

Keywords: COVID-19, CT score, IL-6, intensive care

References

  1. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020;8:475-81.
  2. Sun P, Qie S, Liu Z, Ren J, Li K, Xi J. Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis. J Med Virol 2020;92:612–7.
  3. Rodriguez-Moralesa AJ, Cardona-Ospinaa JA, Gutiérrez-Ocampoa E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis 2020;34:101623.
  4. Al-Ania F, Chehade S, Lazo-Langner A. Thrombosis risk associated with COVID-19 infection. A scoping review. Thromb Res 2020;192:152-60.
  5. Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect 2020;9:1123-30.
  6. Yang R, Li X, Liu H, Zhen Y, Zhang X, Xiong Q, et al. Chest CT Severity Score: An Imaging Tool for Assessing Severe COVID-19. J Thorac Imaging 2020;2.
  7. T.C. Sağlık Bakanlığı. Covid 19 Salgın Yönetimi ve Çalışma Rehberi, Bilimsel Danışma Kurulu Çalışması. (05.07.2020) Available from: URL: https://covid19.saglik.gov.tr/Eklenti/38700/0/covid-19salginyonetimivecalismarehberipdfpdf.pdf
  8. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: Glossary of Terms for Thoracic Imaging. Radiology 2008;246:697-722.
  9. Zhang R, Ouyang H, Fu L, Wang S, Han J, Huang K, et al. CT features of SARS-CoV-2 pneumonia according to clinical presentation: a retrospective analysis of 120 consecutive patients from Wuhan city. Eur Radiol 2020;30:4417–26.
  10. Devecioğlu Ö. COVID-19 ve Hemofagositik Lenfohistiyositoz. SABİAD 2020;3:49-52.
  11. Bıçakçı Z, Metin A. Hemofagositik Lenfohistiyositoz: Olası Patogeneze Bakış. Turkiye Klinikleri J Pediatr 2011;20:241-50.
  12. McGonagle D, Sharif K, O’ Regan A, Bridgewood C. The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease. Autoimmun Rev 2020;19:102537.
  13. Liu KC, Xu P, Lv WF, Qiu XH, Yao JL, Gu JF, et al. CT manifestations of coronavirus disease-2019: A retrospective analysis of 73 cases by disease severity. Eur J Radiol 2020;126:108941.
  14. Jekarl DW, Lee SY, Lee J, Park YJ, Kim Y, Park JH, et al. Procalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis. Diagn Microbiol Infect Dis 2013;75:342-7.
  15. Qu J, Lü X, Liu Y, Wang X. Evaluation of procalcitonin, C-reactive protein, interleukin-6 & serum amyloid A as diagnostic biomarkers of bacterial infection in febrile patients. Indian J Med Res 2015;141:315–21.
  16. Lacour AG, Gervaix A, Zamora SA, Vadas L, Lombard PR, Dayer JM, et al. Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localising signs. Eur J Pediatr 2001;160:95-100.
  17. Ding X, Xu J, Zhou J, Long Q. Chest CT findings of COVID-19 pneumonia by duration of symptoms. Eur J Radiol 2020;127:109009.

How to cite?

1.
Karayel A, Özgültekin A, Yağcı B, Sari A, Balık Y, Aksaray S, et al. Do IL-6 Levels and Other Inflammatory Parameters Correlate with the Lung Computed Tomography Involvement Scores in Critical COVID-19 Patients?. Turk J Intensive Care. 2020;18:39-45. https://doi.org/10.4274/tybd.galenos.2020.96168